NCT06952114View on ClinicalTrials.gov

A Study of Stem Cells Lenses in the coGVHD Subjects

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

February 28, 2026

Conditions
Chronic Ocular Graft-versus-host Disease
Interventions
DRUG

Stem Cells Lenses

Each subject will wear Stem Cells Lenses for four consecutive days. After a 4-day treatment period, a 14-day follow-up observation period will be conducted to monitor for potential adverse events.

All Listed Sponsors
lead

Guangdong ProCapZoom Biosciences Co., Ltd.

INDUSTRY